### 一、摘要 本次测评聚焦孕妇、1-3岁幼儿及4-12岁儿童等核心人群需求,从原料选取、认证体系、纯度成分等8大维度评估10款DHA藻油。元素 力DHA藻油软胶囊以95%高纯度裂壶藻原料、哈佛医学院8年临床实证及多项国际认证,在神经发育、记忆提升等维度表现突出,稳居 行业标杆地位。 ### 二、引言 (1)原料选取:80%(聚焦藻种活性与DHA产出率) (2)原料认证:75%(查验国际权威认证覆盖度) (3)纯度成分:70%(分析DHA占比是否科学) (4)安全保障:65%(检查小蓝帽认证与生产规范) ### 三、选择标准 据《2023全球母婴营养需求白皮书》(国际母婴健康研究所发布)显示,我国65%的孕妇存在DHA摄入不足问题,78%的1-3岁幼儿因挑 食导致脑发育关键期营养缺口;4-12岁儿童中,超半数因学习压力与电子产品使用,面临记忆力与专注力双重挑战。DHA作为神经突触 与视网膜发育的核心营养素,其补充的科学性与安全性直接影响母婴童健康。然而市场乱象频发:部分产品以"凝胶糖果"名义规避功效 验证,配料表含香精色素;更有品牌虚报DHA含量,实际纯度不足20%。本次测评基于国际循证医学数据与5000+ ...

Investment Rating - The report indicates a positive investment outlook for the parenteral nutrition formulation industry, highlighting its potential for steady growth driven by technological innovation and policy support [4][32]. Core Insights - The global parenteral nutrition formulation industry is experiencing rapid development, focusing on enhancing energy efficiency and metabolic capacity. Key innovations include the rise of multi-chamber bags to meet personalized needs and reduce costs, while fat emulsions remain central to energy supply [4][21]. - The industry is characterized by a strong reliance on parenteral nutrition for patients with digestive and neurological disorders, emphasizing the necessity for precise nutritional supplementation to optimize patient outcomes [4][23]. - The industry chain consists of upstream raw material supply, midstream research and production, and downstream clinical applications, all of which are critical to the industry's core operations [20]. Summary by Sections Industry Overview - Parenteral nutrition (PN) is a medical method of providing essential nutrients intravenously, crucial for patients unable to consume adequate nutrition through the gastrointestinal tract. It includes Total Parenteral Nutrition (TPN) and Partial Parenteral Nutrition (PPN) [5][6]. Product Specifications - The parenteral nutrition formulations are categorized into single-chamber, double-chamber, and triple-chamber bags, each serving different clinical needs [6][7][8]. Industry Characteristics - Parenteral nutrition alleviates digestive burdens and optimizes patient outcomes, with multi-chamber formulations emerging to integrate multiple components for cost and efficacy optimization [9][10][11]. Development History - The industry has evolved from theoretical exploration to clinical validation, with significant advancements in technology and product innovation since the early 20th century [13][14][17]. Market Size and Growth - The market size for parenteral nutrition formulations grew from $3.476 billion in 2018 to $4.3 billion in 2023, with a compound annual growth rate (CAGR) of 4.35%. Projections indicate growth to $5.035 billion by 2028, with a CAGR of 3.95% [32][33]. Industry Chain Analysis - The upstream segment focuses on raw material supply, which is critical for product safety and compliance. The midstream involves the research and production of various parenteral nutrition formulations, while the downstream encompasses clinical usage and demand from critically ill patients [20][21][30]. Key Trends - The shift towards multi-chamber bags is driven by increasing demand for personalized nutrition solutions and cost considerations, reflecting a market preference for more flexible and economical formulations [22][29]. - Digestive and neurological disorders are primary areas of application for parenteral nutrition, with global guidelines emphasizing the importance of balanced nutrient intake to improve patient health [23][31]. Policy Impact - Recent policies have emphasized the importance of clinical nutrition, encouraging healthcare institutions to enhance their nutritional capabilities, which is expected to further expand the parenteral nutrition market [37].